Close Menu

NEW YORK (GenomeWeb) – Luminex reported after the close of the market on Monday that its fourth quarter revenues rose 4 percent year over year, in line with preliminary estimates.

For the three months ended Dec. 31, 2018, the firm said revenues rose to $81.1 million from $78.2 million a year ago, beating the analysts' consensus estimate of $79.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.